By Professor Craig Anderson

Conference Papers

Horrocks JA; Hackett ML; Anderson CS; House AO, 2004, 'Pharmaceutical interventions for emotionalism after stroke', in Stroke, pp. 2610 - 2611, http://dx.doi.org/10.1161/01.STR.0000145291.71063.94

Hackett ML; Anderson CS; House AO; Horricks JA, 2004, 'Continued uncertainty about the effectiveness of treatments for post-stroke mood disorders: Experience from the Cochrane Stroke Group', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Vancouver, pp. E313 - E313, presented at 5th World Stroke Congress, CANADA, Vancouver, 23 June 2004 - 26 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000221676600951&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hackett ML; House AO; Anderson CS, 2004, 'Interventions for treating depression after stroke: The Cochrane Stroke Group', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Vancouver, pp. E313 - E313, presented at 5th World Stroke Congress, CANADA, Vancouver, 23 June 2004 - 26 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000221676600950&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

House AO; Hackett MI; Anderson CS; Horricks JA, 2004, 'Pharmaceutical interventions for emotionalism after stroke: The Cochrane Stroke Group', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Vancouver, pp. E218 - E218, presented at 5th World Stroke Congress, CANADA, Vancouver, 23 June 2004 - 26 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000221676600384&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Anderson C, 2003, 'The Ontarget and Transcend clinical trials', in International Journal of Clinical Practice, Supplement, pp. 45 - 48

Whitlock G; MacMahon S; Anderson C; Neal B; Rodgers A; Chalmers J, 1997, 'Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease', in Clinical and Experimental Hypertension, pp. 843 - 855, http://dx.doi.org/10.3109/10641969709083190

Back to profile page